Microsaic Systems plc. (3/23/18). "Press Release: Microsaic Signs Commercial Contract with CPI Innovation Services Ltd".

	Region	United Kingdom (GB)
	Organisation	Microsaic Systems plc (AIM: MSYS)
	Organisation 2	Centre for Process Innovation (CPI), National Biologics Manufacturing Centre, Darlington
	Group	United Kingdom (GB) (govt)
	Product	mass spectrometry-based analysis of biopharmaceutical
	Product 2	rPP [recombinant protein production]
	Index term	United Kingdom (govt)–Microsaic: mass spectrometry, 201803– collab evaluating Microsaic MS for online QC in biopharma production at CPI Darlington
	Person	Tracey, Glenn (Microsaic 201709– CEO joined 201503 as COO before Cambridge Temperature Concepts + PerkinElmer)
	Person 2	Metcalf, Bevan John (Microsaic 201512– Finance Director before Beowulf Mining + Afferro + African Eagle + Orion + GSK)

Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry instruments, is pleased to announce a commercial contract with UK based technology and innovation centre, the Centre for Process Innovation (CPI).

The project will focus on examining the potential of the Microsaic Mass Spectrometry (MS) offering as an online, deployable tool for the elucidation of biopharmaceutical or biologic structure during the manufacturing or bioprocessing workflow. Microsaic’s technology is a powerful point of use analysis tool which can be integrated into complex manufacturing workflows, which has the potential to be utilised in upstream cell media, or downstream biologic purification. A typical workflow could benefit from real-time data to drive production optimisation, ensure process control compliance, and reduce risk for the final product.

CPI brings together state of the art facilities and technical expertise to help companies overcome innovation challenges in the manufacture of biologics. CPI is the UK’s national technology and innovation centre for the process manufacturing industries. At the National Biologics Manufacturing Centre in Darlington, UK, CPI combines state of the art facilities and technical expertise to support the growth and development of the UK biologics industry and supply chain.

Glenn Tracey, CEO, commented “The UK is well positioned as one of the leading countries for process innovation, especially for high value biologics. It is fitting, therefore, that two high-technology businesses such as Microsaic and CPI, both based in the UK, should embark on such exciting knowledge-based work, paving the way for enabling technologies to meet the future quality and compliance needs in biopharma.”

For more information, please contact:

Microsaic Systems plc
Glenn Tracey, COO
Bevan Metcalf, FD
+44 (0) 1483 751577

IFC (Financial PR)
Graham Herring
Heather Armstrong
Florence Chandler
+44 (0)20 7638 9571

N+1 Singer (Nominated
Adviser & Broker)
Shaun Dobson
Liz Yong
+44 (0) 20 7496 3000

Record changed: 2023-06-05